allopurinol and Thrombocythemia--Essential

allopurinol has been researched along with Thrombocythemia--Essential* in 2 studies

Other Studies

2 other study(ies) available for allopurinol and Thrombocythemia--Essential

Article	Year
[Cerebral venous thrombosis secondary to essential thrombocythemia]. Revue neurologique, 2007, Volume: 163, Issue:5 Essential thrombocythemia (ET) is a myeloproliferative syndrome; cerebral venous thrombosis (CVT) is a rare complication.. We report the case of a 20-year-old woman with an uneventful history who was admitted with intracranial hypertension syndrome which had developed over the last four months in association with bilateral decline of visual acuity. Physical examination at admission revealed stage II papilloedema and absence of any focal neurological signs. The brain MRI and the venous MRA showed a thrombosis involving the superior longitudinal sinus and the lateral sinus. The etiological analysis disclosed essential thrombocythemia (ET). The patient was given an antiedema and anticoagulant treatment. Later, an etiological cytoreductive therapy was initiated. Signs of intracranial hypertension regressed progressively with persistence of acute visual disorders associated with sequelar optical atrophy. Discussion. ET is a rare cause of CVT. Reports in the literature have discussed the mechanisms, the physiology, the therapeutic modalities and the clinical course of these CVTs secondarily to ET.. Stroke, especially transient ischemic attack, is the usual thrombotic expression of myeloproliferative syndrome. CVT is much more exceptional. Topics: Adolescent; Allopurinol; Brain; Cerebral Veins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Magnetic Resonance Imaging; Thrombocythemia, Essential; Venous Thrombosis	2007
[Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia]. Investigacion clinica, 1996, Volume: 37, Issue:3 A case of essential thrombocytemia treated with alpha interferon is reported, with hematological remission, but as a side effect hypertriglyceridemia is relevant. It was normalized when alpha interferon was stopped. This is the first case of essential thrombocythemia in Venezuela treated with biological modifiers, with hematological remission, but with hypertriglyceridemia as side effect. Topics: Adult; Allopurinol; Female; Humans; Hydroxyurea; Hypertriglyceridemia; Immunologic Factors; Interferon-alpha; Remission Induction; Thrombocythemia, Essential	1996

Article

Year

[Cerebral venous thrombosis secondary to essential thrombocythemia].

Revue neurologique, 2007, Volume: 163, Issue:5

Essential thrombocythemia (ET) is a myeloproliferative syndrome; cerebral venous thrombosis (CVT) is a rare complication.. We report the case of a 20-year-old woman with an uneventful history who was admitted with intracranial hypertension syndrome which had developed over the last four months in association with bilateral decline of visual acuity. Physical examination at admission revealed stage II papilloedema and absence of any focal neurological signs. The brain MRI and the venous MRA showed a thrombosis involving the superior longitudinal sinus and the lateral sinus. The etiological analysis disclosed essential thrombocythemia (ET). The patient was given an antiedema and anticoagulant treatment. Later, an etiological cytoreductive therapy was initiated. Signs of intracranial hypertension regressed progressively with persistence of acute visual disorders associated with sequelar optical atrophy. Discussion. ET is a rare cause of CVT. Reports in the literature have discussed the mechanisms, the physiology, the therapeutic modalities and the clinical course of these CVTs secondarily to ET.. Stroke, especially transient ischemic attack, is the usual thrombotic expression of myeloproliferative syndrome. CVT is much more exceptional.

Topics: Adolescent; Allopurinol; Brain; Cerebral Veins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Magnetic Resonance Imaging; Thrombocythemia, Essential; Venous Thrombosis

2007

[Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia].

Investigacion clinica, 1996, Volume: 37, Issue:3

A case of essential thrombocytemia treated with alpha interferon is reported, with hematological remission, but as a side effect hypertriglyceridemia is relevant. It was normalized when alpha interferon was stopped. This is the first case of essential thrombocythemia in Venezuela treated with biological modifiers, with hematological remission, but with hypertriglyceridemia as side effect.

Topics: Adult; Allopurinol; Female; Humans; Hydroxyurea; Hypertriglyceridemia; Immunologic Factors; Interferon-alpha; Remission Induction; Thrombocythemia, Essential

1996